Thermo Fisher Scientific's SWOT analysis: stock outlook amid market shifts
Thermo Fisher Scientific Inc. (NYSE:TMO), a leading player in the Life Science Tools & Diagnostics sector, has been navigating a complex market landscape characterized by both challenges and ...
Contract Pharma18h
TriLink, Avantor Team Up to Expand Nucleic Acid Access in EMEA
TriLink BioTechnologies, a Maravai LifeSciences company and provider of life science reagents and services, has partnered ...
Avantor, TriLink BioTechnologies partner on nucleic acid solutions in Europe
TriLink BioTechnologies, a Maravai LifeSciences company (MRVI), has partnered with, Avantor (AVTR) to expand availability of its innovative ...
TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe
TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...
Avantor price target raised to $26 from $25 at Barclays
Barclays analyst Luke Sergott raised the firm’s price target on Avantor (AVTR) to $26 from $25 and keeps an Overweight rating on the shares.